Related Experiment Video
Updated: Apr 20, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
C16:0-ceramide signals insulin resistance
Timothy Hla1, Richard Kolesnick2
1Center for Vascular Biology, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Cornell University, New York, NY 10065, USA.
Sphingolipids, like ceramides, contribute to insulin resistance in metabolic syndrome. Research identifies C16:0-ceramide as a key mediator of obesity-related insulin resistance.
Area of Science:
- Biochemistry
- Metabolic Syndrome Research
- Lipidomics
Background:
- Sphingolipids, particularly ceramides, are increasingly implicated in insulin resistance.
- Metabolic syndrome is associated with dysregulation of lipid metabolism.
Purpose of the Study:
- To identify the specific sphingolipids mediating obesity-related insulin resistance.
- To confirm findings across independent research groups.
Main Methods:
- Utilized advanced mouse genetics.
- Employed sophisticated lipidomics techniques.
Main Results:
- Two independent laboratories identified C16:0-ceramide as a principal mediator.
- This specific ceramide links obesity to insulin resistance.
Conclusions:
- C16:0-ceramide is a key molecular player in obesity-induced insulin resistance.
- Advances in technology have enabled precise identification of lipid mediators.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Type II Diabetes II: Pathophysiology
Insulin Secretory Vesicles
Cell Specific Gene Expression
Lipid Catabolism
Type I Diabetes II: Pathophysiology

